Latest News

Jun 08, 2018
G1 Therapeutics Announces Appointment of New Members to the Board of Directors
Jun 02, 2018
G1 Therapeutics Presents Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting